Report Details

Tables and Figures
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Inactivated Vaccine Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Inactivated Vaccine Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Inactivated Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Inactivated Vaccine Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Inactivated Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Vaccine as of 2021)
Table 10. Global Market Inactivated Vaccine Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Inactivated Vaccine Sales Sites and Area Served
Table 12. Manufacturers Inactivated Vaccine Product Type
Table 13. Global Inactivated Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Inactivated Vaccine
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Inactivated Vaccine Market Challenges
Table 22. Market Restraints
Table 23. Global Inactivated Vaccine Sales by Type (K Units)
Table 24. Global Inactivated Vaccine Market Size by Type (M USD)
Table 25. Global Inactivated Vaccine Sales (K Units) by Type (2017-2022)
Table 26. Global Inactivated Vaccine Sales Market Share by Type (2017-2022)
Table 27. Global Inactivated Vaccine Market Size (M USD) by Type (2017-2022)
Table 28. Global Inactivated Vaccine Market Size Share by Type (2017-2022)
Table 29. Global Inactivated Vaccine Price (USD/Unit) by Type (2017-2022)
Table 30. Global Inactivated Vaccine Sales (K Units) by Application
Table 31. Global Inactivated Vaccine Market Size by Application
Table 32. Global Inactivated Vaccine Sales by Application (2017-2022) & (K Units)
Table 33. Global Inactivated Vaccine Sales Market Share by Application (2017-2022)
Table 34. Global Inactivated Vaccine Sales by Application (2017-2022) & (M USD)
Table 35. Global Inactivated Vaccine Market Share by Application (2017-2022)
Table 36. Global Inactivated Vaccine Sales Growth Rate by Application (2017-2022)
Table 37. Global Inactivated Vaccine Sales by Region (2017-2022) & (K Units)
Table 38. Global Inactivated Vaccine Sales Market Share by Region (2017-2022)
Table 39. North America Inactivated Vaccine Sales by Country (2017-2022) & (K Units)
Table 40. Europe Inactivated Vaccine Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Inactivated Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. South America Inactivated Vaccine Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Inactivated Vaccine Sales by Region (2017-2022) & (K Units)
Table 44. Astellas Pharma (Japan) Inactivated Vaccine Basic Information
Table 45. Astellas Pharma (Japan) Inactivated Vaccine Product Overview
Table 46. Astellas Pharma (Japan) Inactivated Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. Astellas Pharma (Japan) Business Overview
Table 48. Astellas Pharma (Japan) Inactivated Vaccine SWOT Analysis
Table 49. Astellas Pharma (Japan) Recent Developments
Table 50. CSL Limited (Australia) Inactivated Vaccine Basic Information
Table 51. CSL Limited (Australia) Inactivated Vaccine Product Overview
Table 52. CSL Limited (Australia) Inactivated Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. CSL Limited (Australia) Business Overview
Table 54. CSL Limited (Australia) Inactivated Vaccine SWOT Analysis
Table 55. CSL Limited (Australia) Recent Developments
Table 56. Emergent BioSolutions (U.S.) Inactivated Vaccine Basic Information
Table 57. Emergent BioSolutions (U.S.) Inactivated Vaccine Product Overview
Table 58. Emergent BioSolutions (U.S.) Inactivated Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. Emergent BioSolutions (U.S.) Business Overview
Table 60. Emergent BioSolutions (U.S.) Inactivated Vaccine SWOT Analysis
Table 61. Emergent BioSolutions (U.S.) Recent Developments
Table 62. GlaxoSmithKline (U.K.) Inactivated Vaccine Basic Information
Table 63. GlaxoSmithKline (U.K.) Inactivated Vaccine Product Overview
Table 64. GlaxoSmithKline (U.K.) Inactivated Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. GlaxoSmithKline (U.K.) Business Overview
Table 66. GlaxoSmithKline (U.K.) Inactivated Vaccine SWOT Analysis
Table 67. GlaxoSmithKline (U.K.) Recent Developments
Table 68. Johnson and Johnson (U.S.) Inactivated Vaccine Basic Information
Table 69. Johnson and Johnson (U.S.) Inactivated Vaccine Product Overview
Table 70. Johnson and Johnson (U.S.) Inactivated Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Johnson and Johnson (U.S.) Business Overview
Table 72. Johnson and Johnson (U.S.) Inactivated Vaccine SWOT Analysis
Table 73. Johnson and Johnson (U.S.) Recent Developments
Table 74. MedImmune (U.S.) Inactivated Vaccine Basic Information
Table 75. MedImmune (U.S.) Inactivated Vaccine Product Overview
Table 76. MedImmune (U.S.) Inactivated Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. MedImmune (U.S.) Business Overview
Table 78. MedImmune (U.S.) Recent Developments
Table 79. Merck and Co (U.S.) Inactivated Vaccine Basic Information
Table 80. Merck and Co (U.S.) Inactivated Vaccine Product Overview
Table 81. Merck and Co (U.S.) Inactivated Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Merck and Co (U.S.) Business Overview
Table 83. Merck and Co (U.S.) Recent Developments
Table 84. Pfizer (U.S.) Inactivated Vaccine Basic Information
Table 85. Pfizer (U.S.) Inactivated Vaccine Product Overview
Table 86. Pfizer (U.S.) Inactivated Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Pfizer (U.S.) Business Overview
Table 88. Pfizer (U.S.) Recent Developments
Table 89. Sanofi Pasteur (France) Inactivated Vaccine Basic Information
Table 90. Sanofi Pasteur (France) Inactivated Vaccine Product Overview
Table 91. Sanofi Pasteur (France) Inactivated Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Sanofi Pasteur (France) Business Overview
Table 93. Sanofi Pasteur (France) Recent Developments
Table 94. Serum Institute of India Pvt (India) Inactivated Vaccine Basic Information
Table 95. Serum Institute of India Pvt (India) Inactivated Vaccine Product Overview
Table 96. Serum Institute of India Pvt (India) Inactivated Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Serum Institute of India Pvt (India) Business Overview
Table 98. Serum Institute of India Pvt (India) Recent Developments
Table 99. Global Inactivated Vaccine Sales Forecast by Region (K Units)
Table 100. Global Inactivated Vaccine Market Size Forecast by Region (M USD)
Table 101. North America Inactivated Vaccine Sales Forecast by Country (2022-2028) & (K Units)
Table 102. North America Inactivated Vaccine Market Size Forecast by Country (2022-2028) & (M USD)
Table 103. Europe Inactivated Vaccine Sales Forecast by Country (2022-2028) & (K Units)
Table 104. Europe Inactivated Vaccine Market Size Forecast by Country (2022-2028) & (M USD)
Table 105. Asia Pacific Inactivated Vaccine Sales Forecast by Region (2022-2028) & (K Units)
Table 106. Asia Pacific Inactivated Vaccine Market Size Forecast by Region (2022-2028) & (M USD)
Table 107. South America Inactivated Vaccine Sales Forecast by Country (2022-2028) & (K Units)
Table 108. South America Inactivated Vaccine Market Size Forecast by Country (2022-2028) & (M USD)
Table 109. Middle East and Africa Inactivated Vaccine Consumption Forecast by Country (2022-2028) & (Units)
Table 110. Middle East and Africa Inactivated Vaccine Market Size Forecast by Country (2022-2028) & (M USD)
Table 111. Global Inactivated Vaccine Sales Forecast by Type (2022-2028) & (K Units)
Table 112. Global Inactivated Vaccine Market Size Forecast by Type (2022-2028) & (M USD)
Table 113. Global Inactivated Vaccine Price Forecast by Type (2022-2028) & (USD/Unit)
Table 114. Global Inactivated Vaccine Sales (K Units) Forecast by Application (2022-2028)
Table 115. Global Inactivated Vaccine Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Inactivated Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Inactivated Vaccine Market Size (M USD), 2017-2028
Figure 5. Global Inactivated Vaccine Market Size (M USD) (2017-2028)
Figure 6. Global Inactivated Vaccine Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Inactivated Vaccine Market Size (M USD) by Country (M USD)
Figure 11. Inactivated Vaccine Sales Share by Manufacturers in 2020
Figure 12. Global Inactivated Vaccine Revenue Share by Manufacturers in 2020
Figure 13. Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Inactivated Vaccine Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Inactivated Vaccine Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Inactivated Vaccine Market Share by Type
Figure 18. Sales Market Share of Inactivated Vaccine by Type (2017-2022)
Figure 19. Sales Market Share of Inactivated Vaccine by Type in 2021
Figure 20. Market Size Share of Inactivated Vaccine by Type (2017-2022)
Figure 21. Market Size Market Share of Inactivated Vaccine by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Inactivated Vaccine Market Share by Application
Figure 24. Global Inactivated Vaccine Sales Market Share by Application (2017-2022)
Figure 25. Global Inactivated Vaccine Sales Market Share by Application in 2021
Figure 26. Global Inactivated Vaccine Market Share by Application (2017-2022)
Figure 27. Global Inactivated Vaccine Market Share by Application in 2020
Figure 28. Global Inactivated Vaccine Sales Growth Rate by Application (2017-2022)
Figure 29. Global Inactivated Vaccine Sales Market Share by Region (2017-2022)
Figure 30. North America Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Inactivated Vaccine Sales Market Share by Country in 2020
Figure 32. U.S. Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Inactivated Vaccine Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Inactivated Vaccine Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Inactivated Vaccine Sales Market Share by Country in 2020
Figure 37. Germany Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Inactivated Vaccine Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Inactivated Vaccine Sales Market Share by Region in 2020
Figure 44. China Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Inactivated Vaccine Sales and Growth Rate (K Units)
Figure 50. South America Inactivated Vaccine Sales Market Share by Country in 2020
Figure 51. Brazil Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Inactivated Vaccine Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Inactivated Vaccine Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Inactivated Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Inactivated Vaccine Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Inactivated Vaccine Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Inactivated Vaccine Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Inactivated Vaccine Market Share Forecast by Type (2022-2028)
Figure 65. Global Inactivated Vaccine Sales Forecast by Application (2022-2028)
Figure 66. Global Inactivated Vaccine Market Share Forecast by Application (2022-2028)